Dr. Debra L. Friedman, MD

  • Nashville, TN
  • Pediatric hematology and oncology physician
NPI1356422604
Publications
197
Clinical trials
4
Hospital affiliations
1
Industry payments
$276
Medical group
1
Practice address
1211 Medical Center Drive, Nashville, TN 37232
Practice phone
Call (615) 322-3454
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Vanderbilt University Medical Center

Hospital · Nashville, Tennessee

Find Dr. Friedman's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Debra L. Friedman is a pediatric hematology and oncology physician in Nashville, Tennessee

Dr. Friedman practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Friedman's NPI, 1356422604, was assigned on October 17, 2006. Dr. Friedman graduated from Rutgers Robert Wood Johnson Medical School in 1991. Dr. Friedman holds Tennessee license 43917.

NPI and contact details
NPI enumeration date
October 17, 2006
NPI status
Active
Practice phone
(615) 322-3454
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
61
Medical school graduation
1991

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data

Dr. Debra L. Friedman practices at Vanderbilt University Medical Center in Nashville, Tennessee

Dr. Friedman's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Source: Dmand AI Affiliation Data

Dr. Debra L. Friedman is affiliated with 1 site of care and 1 medical group

Dr. Friedman's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. The medical group on file is Vanderbilt University Medical Center.

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Debra L. Friedman's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Friedman practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Vanderbilt University Medical CenterAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Friedman practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Vanderbilt University Medical Center and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Debra L. Friedman is one of 141 pediatric hematologys and oncology physicians in Tennessee

Pediatric hematology-oncology is Dr. Friedman's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Friedman is board certified in pediatric hematology-oncology by the American Board of Pediatrics. Dmand AI has Dr. Friedman's licenses on file in 4 states: Tennessee, Alabama, Washington and Pennsylvania.

Specialties and state licenses

  • Pediatric hematology and oncology, TennesseePrimaryLicense 43917 · 2008 to 2026 · taxonomy 2080P0207X
  • Alabama license2020
  • Washington licenseLicense MD00036876 · 1998 to 2010
  • Pennsylvania license1991 to 1998

Pediatric hematologys and oncology physicians near Dr. Friedman

Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Debra L. Friedman's patients have a median age of 13

Across all payers, Dmand AI patient panel data puts Dr. Friedman's median patient age at 13, with 45% women.

Dr. Friedman's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 13

Patient panel by sex, all payers

  • Women45%
  • Men53%

Source: Dmand AI Patient Panel Data

Dr. Debra L. Friedman has 197 publications on record

Dmand AI links 197 papers to Dr. Friedman, published from 2004 to 2025. 2020 was the busiest year, with 10. The most frequent topics are Survivors, Hodgkin Disease and Antineoplastic Combined Chemotherapy Protocols. Dr. Friedman has published most often in Pediatr Blood Cancer. Dr. Friedman's most frequent co-authors are Cindy Schwartz, MD, Adam J. Esbenshade, MD and Joseph P. Neglia, MD, MPH.

Papers197
Years published2004 to 2025

Dr. Friedman's papers by year, 2016 to 2025

Topics Dr. Friedman writes about most

  • Survivors
  • Hodgkin Disease
  • Antineoplastic Combined Chemotherapy Protocols
  • Antineoplastic Agents
  • Neoplasms, Second Primary
  • Hematopoietic Stem Cell Transplantation
  • Retinoblastoma
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma

Dr. Friedman's most frequent co-authors

Recent publications by Dr. Friedman

See all 197 publications and co-authors

See who Dr. Friedman researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Friedman works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Debra L. Friedman has worked on 4 clinical trials

Dmand AI links Dr. Friedman to 4 clinical trials. 2 are still active or recruiting. Conditions studied include Lymphoma, Large-Cell, Anaplastic and Burkitt Lymphoma. Children's Oncology Group sponsors the most, 3.

Conditions in Dr. Friedman's trials

  • Lymphoma, Large-Cell, Anaplastic
  • Burkitt Lymphoma

Investigators on the most trials with Dr. Friedman

Recent clinical trials with Dr. Friedman

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Debra L. Friedman received $276 in industry payments from 2018 to 2025

CMS Open Payments shows 4 general payments to Dr. Friedman from 4 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $125.

General payments to Dr. Friedman by program year, 2018 to 2025

Companies that paid Dr. Friedman the most, 2018 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Friedman

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Debra L. Friedman has 3 awards and honors on record

Dmand AI lists 3 awards for Dr. Friedman.

Awards and honors for Dr. Friedman

  1. Undated
    • America's Top Doctors
    • America's Top Doctors for Cancer
    • Nashville Lifestyles Magazine

Source: Dmand AI Professional Profile Data

Dr. Debra L. Friedman graduated from Rutgers Robert Wood Johnson Medical School

Dr. Friedman graduated from Rutgers Robert Wood Johnson Medical School in 1991. Dr. Friedman is a member of ASCO.

  1. Medical schoolRutgers Robert Wood Johnson Medical School
  2. Board certified in pediatric hematology-oncologyAmerican Board of Pediatrics

Source: Dmand AI Professional Profile Data

Dr. Debra L. Friedman accepts plans from 13 insurance carriers

Dr. Friedman is in network with 13 carriers, including United Healthcare, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.

Plan types Dr. Friedman accepts, by number of carriers

  1. HMO7
  2. PPO7
  3. EPO4
  4. POS4
  5. Medicaid2
  6. Medicare2

Source: Dmand AI Insurance Network Data

Sources for Dr. Debra L. Friedman's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Debra L. Friedman

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Debra L. Friedman's NPI number?

Dr. Debra L. Friedman's NPI number is 1356422604. It was assigned on October 17, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Debra L. Friedman?

Dr. Debra L. Friedman is a pediatric hematology and oncology physician in Nashville, Tennessee. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).

Where does Dr. Debra L. Friedman practice?

Dr. Friedman practices at 1211 Medical Center Drive, Nashville, TN 37232. Dr. Friedman's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

What is Dr. Debra L. Friedman's office phone number?

The practice phone on file for Dr. Friedman is (615) 322-3454.

What is Dr. Debra L. Friedman's medical license number?

Dr. Friedman holds Tennessee license 43917, one of the licenses on file in 4 states.

Which states has Dr. Debra L. Friedman been licensed in?

Dmand AI has state licenses on file for Dr. Friedman in Tennessee (2008 to 2026), Alabama (2020), Washington (1998 to 2010) and Pennsylvania (1991 to 1998).

Which hospitals is Dr. Debra L. Friedman affiliated with?

Dr. Friedman practices at Vanderbilt University Medical Center in Nashville, Tennessee.

What medical group is Dr. Debra L. Friedman part of?

Dr. Friedman is linked to Vanderbilt University Medical Center.

Is Dr. Debra L. Friedman board certified?

Yes. Dr. Friedman is board certified in pediatric hematology-oncology by the American Board of Pediatrics.

Where did Dr. Debra L. Friedman go to medical school?

Dr. Friedman graduated from Rutgers Robert Wood Johnson Medical School in 1991.

Show 5 more questionsShow fewer questions

Has Dr. Debra L. Friedman received payments from drug or device companies?

CMS Open Payments shows $276 in general payments to Dr. Friedman from 4 companies from 2018 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.

How long has Dr. Debra L. Friedman been practicing?

Dr. Friedman graduated from medical school in 1991, 35 years ago.

Does Dr. Debra L. Friedman do research?

Dmand AI links 197 publications to Dr. Friedman, published from 2004 to 2025. Dr. Friedman has worked on 4 clinical trials.

Who does Dr. Debra L. Friedman publish with?

Dr. Friedman's most frequent co-authors are Cindy Schwartz, MD (22 shared papers), Adam J. Esbenshade, MD (17 shared papers) and Joseph P. Neglia, MD, MPH (17 shared papers).

What insurance does Dr. Debra L. Friedman accept?

Dr. Friedman is in network with 13 carriers, including United Healthcare, Aetna and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.

Selling to pediatric hematology-oncology practices?

See pediatric hematologys and oncology physicians in Tennessee by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)